In the context of hematological malignancies, Steinbach et al. (2006), Steinbach et al. (2015) verified that SPAG6 expression was increased in patients with AML, whereas SPAG6 expression returned to normal levels in patients with sustained complete remission. The gene discussed is SPAG6; the disease is acute myeloid leukemia.